Symbols

MIRM

Mirum·NASDAQ

--(--)

MIRM fundamentals

MIRM Q4 2025 Earnings

Mirum (MIRM) released its earnings on Feb 25, 2026: revenue was 148.93M (YoY +49.81%), beat estimates; EPS was -0.1 (YoY +79.59%), missed estimates.

Revenue / YoY

148.93M

+49.81%

EPS / YoY

-0.1

+79.59%

Report date

Feb 25, 2026

MIRM Earnings Call Summary for Q4,2025

Revenue Growth: 55% YoY to $521M in 2025; 2026 guidance $630-650M driven by LIVMARLI and pipeline expansion.
Pipeline Milestones: 4 registrational readouts in 18 months (Volixibat PSC Q2 2026, Brelovitug HDV H2 2026).
Financial Strength: $391M cash, positive 2025 operating cash flow, 2027 return to positive cash flow.
Strategic Investments: $150M+ for Brelovitug CMC; 2026 R&D spend up 75% to $336M.

Earnings

EPS

Revenue

Revenue & Expenses

MIRM has released its 2025 Q4 earnings report, with revenue of 148.93M, reflecting a YoY change of 49.81%, and net profit of -5.73M, showing a YoY change of 75.91%. The Sankey diagram below clearly presents MIRM's revenue sources and cost distribution.

Key Indicators

Mirum (MIRM) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Mirum (MIRM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Mirum (MIRM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Mirum (MIRM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown